Vimarsana
Biggest News Aggregation in the World

Page 27 - Srinivas Murthy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Srinivas Murthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Srinivas Murthy Today - Breaking & Trending Today

What we know about Merck's experimental pill to treat COVID-19 - Vimarsana News

What we know about Merck's experimental pill to treat COVID-19

Infectious disease specialists who spoke with CBC News have 'cautious optimism' about the new experimental pill-based treatment for COVID-19, molnupiravir, but say vaccination is still the most effective way to reduce risk.

Source: cbc.ca
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This study compares the effect of convalescent plasma vs no convalescent plasma on the outcome of organ support–free days in the hospital among critically ill a

Sask. faces shortage of COVID-19 medication - Vimarsana News

Sask. faces shortage of COVID-19 medication

Saskatchewan's Ministry of Health said Thursday it had enough tocilizumab to treat about 21 patients, or enough supply for about two weeks.

Sask. short on COVID-19 medication | Melfort Journal - Vimarsana News

Sask. short on COVID-19 medication | Melfort Journal

Saskatchewan's Ministry of Health said Thursday it had enough tocilizumab to treat about 21 patients, or enough supply for about two weeks.

Sask. short on COVID-19 medication | Nipawin Journal - Vimarsana News

Sask. short on COVID-19 medication | Nipawin Journal

Saskatchewan's Ministry of Health said Thursday it had enough tocilizumab to treat about 21 patients, or enough supply for about two weeks.